GERMANTOWN, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and service provider, today announced that Orgenesis’ Chief Scientific Officer, Sara Ferber Ph.D. will present the Company’s novel and proprietary autologous….